Cardiff University develops AI tool to detect type 1 diabetes in childhood

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN


Researchers from Cardiff University have developed a tool that uses AI technology to predict whether certain children may go on to develop Type 1 diabetes and could lead to an earlier diagnosis.

Funding from Diabetes UK, enabled researchers at Cardiff University to use AI technology and electronic health records for children to develop a predictive tool. Data from one million children was used to train the tool to spot patterns in GP records that could highlight a potential case of type 1 diabetes.

The team tested different combinations of factors marked in GP records, such as urinary infections, bedwetting, family history and being prescribed antibiotics, to learn which factors could best predict a diagnosis of the condition.

To test their methods, they then used the tool on 1.5million children who had already received a type 1 diagnosis.

They determined that when they set the level to 10% (where 1 in 10 children consulting with a GP would raise an alert) the tool was successful in identifying 75 percent of children who would go on to get a diabetes diagnosis within 90 days.

The use of AI would allow children to receive a diagnosis 11 days earlier than they had, on average. This head start means they have earlier access to life-saving insulin therapy, and the risk of diabetic ketoacidosis (DKA) can be significantly reduced.

Dr Julia Townson, senior research fellow at Cardiff University’s center for trials research, said: “We are now looking to see how this tool might work with primary care computer systems. If possible, this would enable us to carry out a feasibility study to assess the acceptability of the tool with GPs. Use of the tool may be a few years away yet – but we are hopeful it will provide a vital new avenue for early diagnosis of diabetes which could save lives. ”

It was also announced this week that all patients with type 1 diabetes would be eligible for new technology on the NHS following the publication of new guidance.





Source link

TheHealthReporter

TheHealthReporter

Recent Posts

Enhance your Cisco HIMSS24 experience
The Cisco Customer Experience Healthcare Practice helps customers leverage the use of Cisco technology...
Read More
HIMSS 2024 Find out before you go
The future of healthcare is coming into focus! Now more than ever, we believe that technology is a critical...
Read More
How GLP-1 Drug Success Is Transforming Healthcare Revenue: Is Your Organization Ready?
The huge revenue opportunity arising from the recent success of GLP-1 drugs is not just for pharmaceutical...
Read More

Related Posts